The above makes it sound as though there's no problem, but that’s not the case. The USPSTF guidelines just issued* say that Cologuard is no better than the old FIT test (which is one of the components of Cologuard). Cologuard has yet to receive reimbursement from most private payers, and USPSTF’s opinion will make it harder to do so.
*No link (sorry).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.